Send feedback

NPHP1 p.Ser574Leu

c.1721C>T · rs138181219 · VCV330728

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 5 submitters
AlphaMissense
likely benign
0.0856 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0421%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
4
nephronophthisis 1

Computational evidence

Protein change
AlphaMissense0.0856likely benign
REVEL0.092moderately benign-leaning
SaProtLLR -5.74tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI<0.2all four deltas below 0.2 · G>T here scores Δ0.47 · evaluated, not missing
Constraint at this position
ConservationphyloP 7.4GERP 0.49, phastCons 1
Regional constrainto/e 0.96unconstrained · MANE · 81 kb · p 0.26 · regional, not allelic
Overall
CADD25.1PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM S629L vs ClinVar S574L) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0421% European (non-Finnish) · 497/1,179,136 alleles
Filtering AF 0.039% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0379%
Overall 0.0342% 552/1,612,702 alleles · ultra-rare exomes 525/1,460,566 · genomes 27/152,136 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.122% 822
European (non-Finnish)grpmax 0.0421% 2,373
Remaining individualsnot grpmax-eligible 0.0224% 4,463
East Asian 0.00446% 22,424
Admixed American 0.00167% 59,998
Finnishnot grpmax-eligible 0.00157% 63,646
African / African-American 0.00133% 74,988

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
NPHP1
Protein
p.Ser574Leu
Coding
c.1721C>T
MANE Select
NM_001128178
dbSNP
rs138181219
Type
single nucleotide variant
Location
chr2:110125677 (GRCh38)
Gene constraint
LOEUF 0.92 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 76.22 · 2 PDB
Full NPHP1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/nphp1-p-ser574leu (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown